Table 1 List of ESC guidelines used for this summary. 1 = guideline contains specific recommendations regarding the use of CMR; 2 = guideline mentions scenarios in which CMR may be used, but without giving any specific recommendation; 3 = guideline does not mention CMR at all
From: Role of cardiovascular magnetic resonance in the guidelines of the European Society of Cardiology
Nr. | Title | Year | Role of CMR |
|---|---|---|---|
1 | ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death [6] | 2015 | 1 |
2 | ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension [7] | 2015 | 2 |
3 | ESC guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation [9] | 2015 | 1 |
4 | ESC Guidelines for the diagnosis and management of pericardial diseases [11] | 2015 | 1 |
5 | ESC Guidelines for the management of infective endocarditis [12] | 2015 | 1 |
6 | ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy [14] | 2014 | 1 |
7 | ESC Guidelines on the diagnosis and treatment of aortic diseases [15] | 2014 | 1 |
8 | ESC/EACTS Guidelines on myocardial revascularization [16] | 2014 | 1 |
9 | ESC Guidelines on the diagnosis and management of acute pulmonary embolism [17] | 2014 | 1 |
10 | ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management [18] | 2014 | 1 |
11 | ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD [19] | 2013 | 2 |
12 | ESC guidelines on the management of stable coronary artery disease [20] | 2013 | 1 |
13 | ESC Guidelines on cardiac pacing and cardiac resynchronization therapy [21] | 2013 | 2 |
14 | ESH/ESC Guidelines for the management of arterial hypertension [22] | 2013 | 1 |
15 | ESC/EACTS Guidelines on the management of valvular heart disease [23] | 2012 | 2 |
16 | Focused update of the ESC Guidelines for the management of atrial fibrillation [24] | 2012 | 3 |
17 | ESC/ACCF/AHA/WHF Third universal definition of myocardial infarction [25] | 2012 | 2 |
18 | ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation [26] | 2012 | 1 |
19 | ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure [27] | 2012 | 1 |
20 | European Guidelines on cardiovascular disease prevention in clinical practice [28] | 2012 | 2 |
21 | ESC/EAS Guidelines for the management of dyslipidaemias [29] | 2011 | 3 |
22 | ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation [10] | 2011 | (new guideline 2015) |
23 | ESC Guidelines on the management of cardiovascular diseases during pregnancy [30] | 2011 | 1 |
24 | ESC Guidelines on the diagnosis and treatment of peripheral artery diseases [31] | 2011 | 1 |
25 | ESC Guidelines for the management of grown-up congenital heart disease [32] | 2010 | 2 |
26 | Focused Update of ESC Guidelines on device therapy in heart failure [34] | 2010 | 3 |
27 | Guidelines on the prevention, diagnosis, and treatment of infective endocarditis [23] | 2009 | (new guideline 2015) |
28 | Guidelines for the diagnosis and management of syncope [35] | 2009 | 2 |
29 | Guidelines for the diagnosis and treatment of pulmonary hypertension [8] | 2009 | (new guideline 2015) |